Clinical Trials Logo

Palmar or Plantar Warts clinical trials

View clinical trials related to Palmar or Plantar Warts.

Filter by:
  • None
  • Page 1

NCT ID: NCT04814446 Recruiting - Clinical trials for Palmar or Plantar Warts

Nonavalent HPV Vaccine in the Treatment of Difficult-to-treat Palmo-plantar Warts

VAC-WARTS
Start date: June 29, 2022
Phase: Phase 3
Study type: Interventional

Cutaneous viral warts are very common and are caused by the human papilloma virus (HPV). Most people experience warts in one form or another at some point in their lives. Cutaneous warts are related to different types of HPV. For the palms and soles, HPV 2 has been the most frequently found but HPV 1, 4, 27, and 57 have also been described. Our hypothesis is that vaccination by nonavalent vaccine against HPV could lead to a complete resolution of difficult-to-treat palmo-plantar warts patients of more than 15 years and 3 months of age.